Niagen Bioscience, Inc.
Nasdaq · Healthcare · Medicinal Chemicals & Botanical Products · Los Angeles, CA
NAGE chart
What traders are saying about $NAGE
Latest postsNiagen Bioscience, Inc. news
- Niagen Bioscience (Nasdaq:NAGE) - Stock Analysis
Simply Wall Street ·
- ChromaDex Corp (OCD1.DU) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Niagen Bioscience, Inc. (NAGE) stock price, news, quote and history
Yahoo Finance UK ·
- Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Yahoo Finance ·
- Niagen Bioscience Inc
Reuters ·
- Niagen Bioscience at LD Micro event: rare-disease push takes center stage
Investing.com ·
- Niagen Bioscience launches Tru Niagen Skincare with NanoCloud product debut
Traders Union ·
- Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® Product
Yahoo Finance ·
- Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Yahoo Finance ·
- Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
Yahoo Finance ·
- Niagen Bioscience to Present at LD Micro 20th Annual Main Event
Yahoo Finance ·
- Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®" a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
Yahoo Finance ·
Niagen Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $129.4M | $99.6M | $83.6M | $72.0M |
| Net income | $17.4M | $8.6M | -$4.9M | -$16.5M |
| Diluted EPS | $0.20 | $0.11 | $-0.07 | $-0.24 |
| Total assets (year end) | $106.4M | $68.3M | $55.0M | $54.1M |
| Cash and equivalents (year end) | – | $44.5M | $27.2M | $20.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Niagen Bioscience, Inc.
- Ticker
- NAGE (Nasdaq)
- Industry
- Medicinal Chemicals & Botanical Products
- Headquarters
- Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
Frequently asked questions
What exchange is Niagen Bioscience, Inc. listed on?
Niagen Bioscience, Inc. trades on the Nasdaq under the ticker symbol NAGE.
What industry is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is classified by the SEC under "Medicinal Chemicals & Botanical Products", part of the Healthcare sector on StockTweeting.
Where is Niagen Bioscience, Inc. headquartered?
Niagen Bioscience, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Niagen Bioscience, Inc.'s fiscal year end?
Niagen Bioscience, Inc.'s fiscal year ends on December 31.
How much revenue did Niagen Bioscience, Inc. report?
Niagen Bioscience, Inc. reported $129.4M in revenue for calendar year 2025, according to its SEC filings.